Stock Taper Premium Revenue: $10.2 billion for Q1 2026.
Adjusted Earnings Per Share (EPS): $2.35.
Medical Care Ratio (MCR): 91.1% consolidated; Medicaid at 92%, Medicare at 89.8%, and Marketplace at 84%.
Adjusted Pretax Margin: 1.6%.
Operating Cash Flow: $1.1 billion, driven by timing of government payments.
Debt-to-Capital Ratio: Approximately 48%, with a target in the low 40s.
Medicaid Business: Focus on enhancing medical cost management protocols; the acuity shift observed in 2025 is not expected to recur in 2026.
Medicare: Transition of MMP members to new integrated products is progressing well; strategic focus on Duals business.
Marketplace: Membership increased to 305,000, with a concentration in the silver tier for stability.
Investor Day: Scheduled for May 8, 2026, where detailed long-term growth strategies and financial outlook through 2029 will be presented.
2026 Full Year Guidance: Reaffirmed premium revenue of approximately $42 billion and adjusted EPS of at least $5.
Medicaid Membership: Expected decline of 6% (up from previous guidance of 2%), with a projected year-end membership of approximately 4.5 million.
Medical Cost Trend: Assumed at 5% for 2026, with expectations for favorable medical cost management.
Earnings Seasonality: Anticipated to be front-end loaded, with a majority of earnings expected in the first half of the year.
Membership Decline: Increased Medicaid membership attrition due to state-specific factors, notably in California, Illinois, New York, and Texas, which may impact revenue.
Regulatory Environment: Ongoing changes in Medicaid work requirements and redeterminations could pose challenges in membership retention and administrative processes.
Market Volatility: The Marketplace segment remains volatile, with caution advised for future pricing cycles.
Debt Levels: While manageable, the current debt-to-cap ratio is higher than desired, indicating a need for careful financial management moving forward.
Membership Dynamics: The company is closely monitoring state-specific trends affecting Medicaid enrollment, with a noted increase in low and no utilizers.
Cash Flow Management: Strong cash flow at the parent company level is expected to exceed $600 million by year-end, supporting growth initiatives.
Market Position: Molina is positioned to capitalize on potential M&A opportunities as some Medicaid plans exit the market, although the focus remains on strategic alignment.
Community Engagement Requirements: There is uncertainty regarding the implementation of community engagement requirements in Medicaid, with ongoing discussions with state partners.
Operational Timing: The first quarter's G&A expenses were higher due to timing issues related to IT projects and preparations for new contracts, but the full-year guidance remains unchanged. This summary encapsulates the key elements from Molina Healthcare's Q1 2026 earnings call, providing a balanced view of the company's performance, strategic direction, and challenges ahead.
SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT